Overview

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Despite treatment with anti-HIV drugs, people infected with HIV continue to have problems with their immune systems. This study will evaluate whether the drug thalidomide, which stimulates the immune system's T cells, can improve immune system function in people with HIV.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Thalidomide